Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method

- Development of a customised RP-HPLC method for pegylated IFN-α2a separation.
- Quantitative calibration of customised RP-HPLC method with EP CRS of non-pegylated IFN-α2a.
- Mass determination by customised RP-HPLC of a PEG20-IFN-α2a product, Reiferon Retard®.